Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-106912
Filing Date
2025-08-12
Accepted
2025-08-12 07:10:48
Documents
77
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krro-20250630.htm   iXBRL 10-Q 2514919
2 EX-31.1 krro-ex31_1.htm EX-31.1 19085
3 EX-31.2 krro-ex31_2.htm EX-31.2 18955
4 EX-32.1 krro-ex32_1.htm EX-32.1 11208
  Complete submission text file 0000950170-25-106912.txt   9263572

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krro-20250630.xsd EX-101.SCH 1457825
80 EXTRACTED XBRL INSTANCE DOCUMENT krro-20250630_htm.xml XML 1437761
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 251204004
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)